Stigma: how it affects the substance use disorder patient

Zwick, Janet; Appleseth, Hannah; Arndt, Stephan

doi:10.1186/s13011-020-00288-0

Cited by 81 publications

(57 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Substance use has been conceptualized differently throughout history but has always been rife with stigma (Pecoraro et al, 2012). Stigma is primarily influenced by perceived cause and controllability (Zwick et al, 2020). Various and often overlapping stigmas exist for individuals with a substance use disorder (SUD) or opioid use disorder (OUD) and those seeking or accessing MOUD.…”

Section: Resultsmentioning

confidence: 99%

Medication for opioid use disorder in rural America: A review of the literature.

Showers¹,

Dicken²,

Smith³

et al. 2021

Journal of Rural Mental Health

View full text Add to dashboard Cite

The United States finds itself amid a 20-year battle with an epidemic of opioid-related overdose deaths. Medication for opioid use disorder (MOUD), a highly researched and efficacious treatment approach, remains out of reach for many individuals living in rural parts of the country. A variety of factors contribute to the disparity in access. Stigma related to substance use serves as a significant barrier in public policy enactment, making funding for MOUD scarce in rural communities. The demand for authorized providers of MOUD in rural parts of the country is high, and the number of available providers is low, significantly contributing to the disparity in care. In 2016 the United States Congress passed the Comprehensive Addiction and Recovery Act (CARA), allocating funds to rural parts of the country to enhance their MOUD capacity. While this legislation has shown great promise in increasing access, several significant barriers prevent the expansion of services necessary in these areas. Creative solutions to these barriers exist. A multifaceted approach to include elements of community stigma reduction, methods to increase provider waiver attainment and utilization, expansion of Project Echo, and the expansion of telehealth services are recommended.

show abstract

Section: Resultsmentioning

confidence: 99%

Medication for opioid use disorder in rural America: A review of the literature.

Showers¹,

Dicken²,

Smith³

et al. 2021

Journal of Rural Mental Health

View full text Add to dashboard Cite

show abstract

“…Several studies have reported the negative impact of methamphetamine use on physical and mental health. For example, Darke et al [ 50 ], Stuart et al [ 51 ] , Zwick et al [ 52 ], and Crapanzano et al [ 53 ] reported that among substance users, stigma had a great adverse impact on their health. Wogen et al [ 17 ] reported that the stigma experienced among substance users had a negative impact on accessing mental health clinics and became a severe mental health problem.…”

Section: Discussionmentioning

confidence: 99%

Drivers, facilitators, and sources of stigma among Akha and Lahu hill tribe people who used methamphetamine in Thailand: a qualitative approach

et al. 2022

View full text Add to dashboard Cite

Background The stigma related to drug use has several impacts, including effects on users’ physical and mental health. Methamphetamine is a major drug that is used among hill tribes living in the border areas of Thailand and Myanmar. This study aimed to understand the drivers, facilitators, sources and outcomes of the stigma surrounding drug use, including the expectations among Akha and Lau hill tribe people who use methamphetamine in Thailand. Methods Qualitative data were used to elicit information from key informants and members of the hill tribes who used methamphetamine. The questionnaire was developed from a literature review and tested for validity before use. In-depth interviews were used to confidentially gather information from the participants in private rooms in villages. Each interview lasted 45 min, and a thematic analysis was conducted to examine the findings. Results A total of 46 participants were recruited to provide information; 95.7% were male, and 50.0% were aged 15–34 years. The majority were married (47.8%), 76.1% were Christian, and 45.7% graduated high school. Six drivers of stigma were detected: being poor, illiterate, unemployed, working aged, female, and married. Culture and tribe acted as facilitators of the stigma attached to methamphetamine use. Four sources of stigma were found: self, family members, peers, and community members. Three outcomes of stigma were determined: poor physical health, mental health, and relationships with others. There were four levels of expectations: no expectations, expectations for themselves, expectations for their family members, and expectations for their community members. Conclusions Many personal traits, people living nearby, and socioeconomic factors, including culture and tribes, act as drivers, facilitators, and sources of stigma among hill tribe people who use methamphetamine. A program to reduce methamphetamine use among hill tribes should be implemented, which could eventually minimize stigma.

show abstract

“…The fact that no respondent-level demographic or other variables were consistently associated with stigma suggested that the hypothetical condition was driving the majority of ratings. This is a positive outcome, because it suggests that efforts to reduce stigma toward a health condition could be effective ( 17 , 30 , 31 ), particularly in healthcare settings ( 17 , 25 , 32 ). Short Brief Intervention and Training (SBIRT) programs with healthcare providers have also been shown to produce enduring reductions in stigma toward persons who have a SUD ( 33 , 34 ).…”

Section: Discussionmentioning

confidence: 99%

Attitudes Toward Organ Donation for Persons Who Have a Substance Use Disorder Relative to Other Health Conditions

et al. 2021

View full text Add to dashboard Cite

Background: Increases in opioid-related overdose and death have led to increases in the number of organs available for donation and transplant, however persons who have a substance use disorder (SUD) may be disadvantaged relative to other health conditions with regard to receiving an organ for transplant.Objective: This study aimed to evaluate perceptions regarding acceptability and priority for organ donation vs. a control condition (resuscitation) for hypothetical persons with nine target health conditions including a substance use disorder, among persons recruited as part of an online survey.Methods: Respondents (N = 285; male = 172, female = 113) recruited from Amazon Mechanical Turk rated acceptability and priority that hypothetical persons representing nine target health conditions expected to influence transplant success (including a SUD) receive an organ transplant and resuscitation via a survey hosted by Qualtrics. Primary outcomes of stigma ratings and priority ranking of persons as a function of the hypothetical target health condition were analyzed using Repeated Measures Analyses of Variance and Bonferroni-corrected t-tests. Demographic information was presented descriptively for all respondents.Results: Ratings for acceptability and priority for persons who had a SUD were generally lower than ratings for other conditions for both organ for transplant and resuscitation, though respondents reported less stigma toward resuscitation, F(8) = 22.35, p <0.001 overall. Respondents were least supportive of persons who smoked cigarettes receiving an organ, p's < 0.001. Priority rankings favored persons who were young or had a history of heart disease. Multivariable models determined that target health condition, F(8) = 33.64, p < 0.001, was a better and more consistent predictor of response than demographic variables that were examined.Conclusions: Data suggest that general perception of acceptability and priority ranking for receipt of life-saving interventions was lower for persons who have a SUD relative to other clinically-relevant health conditions. Research to examine this effect among persons working in the donation system are warranted and efforts to reduce stigma toward persons who have a SUD should be continued.

show abstract

Stigma: how it affects the substance use disorder patient

Cited by 81 publications

References 9 publications

Medication for opioid use disorder in rural America: A review of the literature.

Medication for opioid use disorder in rural America: A review of the literature.

Drivers, facilitators, and sources of stigma among Akha and Lahu hill tribe people who used methamphetamine in Thailand: a qualitative approach

Attitudes Toward Organ Donation for Persons Who Have a Substance Use Disorder Relative to Other Health Conditions

Contact Info

Product

Resources

About